Tech Company Financing Transactions

Sherlock Biosciences Funding Round

Sherlock Biosciences closed a $80 million Series B funding round on 3/8/2022. Investors included Novalis LifeSciences, Albany Partners and Catalio Capital Management.

Transaction Overview

Announced On
3/8/2022
Transaction Type
Venture Equity
Amount
$80,000,000
Round
Series B
Proceeds Purpose
This new funding will drive development of products and partnerships, enabled by this platform, that can operate at ambient temperature without complex instrumentation, opening up a wide range of applications in low resource settings including the home.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Bdwy.
Cambridge, MA 02142
USA
Phone
Undisclosed
Email Address
Overview
Sherlock Biosciences is disrupting diagnostics. Sherlock Biosciences was founded on the belief that we can vastly improve human health and industrial testing worldwide. Diagnostic tests developed with our Engineering Biology platforms will help us deliver results faster, accurately and more affordably.
Profile
Sherlock Biosciences LinkedIn Company Profile
Social Media
Sherlock Biosciences Company Twitter Account
Company News
Sherlock Biosciences News
Facebook
Sherlock Biosciences on Facebook
YouTube
Sherlock Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chairman
Feng Zhang
  Feng Zhang LinkedIn Profile  Feng Zhang Twitter Account  Feng Zhang News  Feng Zhang on Facebook
Chief Executive Officer
Rahul Dhanda
  Rahul Dhanda LinkedIn Profile  Rahul Dhanda Twitter Account  Rahul Dhanda News  Rahul Dhanda on Facebook
Chief Technical Officer
William Blake
  William Blake LinkedIn Profile  William Blake Twitter Account  William Blake News  William Blake on Facebook
Co-Founder
Omar Abudayyeh
  Omar Abudayyeh LinkedIn Profile  Omar Abudayyeh Twitter Account  Omar Abudayyeh News  Omar Abudayyeh on Facebook
Co-Founder
James Collins
  James Collins LinkedIn Profile  James Collins Twitter Account  James Collins News  James Collins on Facebook
Co-Founder
Todd Golub
  Todd Golub LinkedIn Profile  Todd Golub Twitter Account  Todd Golub News  Todd Golub on Facebook
Co-Founder
Jonathan Gootenberg
  Jonathan Gootenberg LinkedIn Profile  Jonathan Gootenberg Twitter Account  Jonathan Gootenberg News  Jonathan Gootenberg on Facebook
Co-Founder
Deborah Hung
  Deborah Hung LinkedIn Profile  Deborah Hung Twitter Account  Deborah Hung News  Deborah Hung on Facebook
Co-Founder
Pardis Sabeti
  Pardis Sabeti LinkedIn Profile  Pardis Sabeti Twitter Account  Pardis Sabeti News  Pardis Sabeti on Facebook
Co-Founder
David Walt
  David Walt LinkedIn Profile  David Walt Twitter Account  David Walt News  David Walt on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/8/2022: Big Bold Health venture capital transaction
Next: 3/8/2022: Filtered venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary